+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Gynecological Devices Market Analysis, Size, Trends 2023-2029 MedSuite Includes: Gynecological Endoscope Devices, Endometrial Ablation Devices, Morcellator Device Market and 7 more.

  • PDF Icon

    Report

  • 332 Pages
  • July 2023
  • Region: United States
  • iData Research
  • ID: 5864090
In 2022, the gynecological devices market in the United States reached a value of approximately $1.3 billion, driven by nearly 3 million gynecological procedures performed annually. Our extensive research in the medical device market encompassed over 70 gynecological device companies across the United States. Through our comprehensive methodology, we analyzed market sizes, unit sales, company market shares, and developed accurate forecasts.

The complete report suite on the U.S. market for gynecological devices covers a wide range of products, including assisted reproduction technology devices, global endometrial ablation, uterine fibroid embolization devices, gynecological endoscopes, gynecological resection electrodes, morcellators, pelvic floor electrical stimulation devices, fluid management devices, pelvic organ prolapse repair devices, and hysterosalpingography (HSG) catheters.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Gynecological Procedure Volumes
  • Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Gynecological Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

U.S. GYNECOLOGICAL DEVICES MARKET INSIGHTS

As companies vie for market share, pricing strategies in the gynecological devices industry become crucial. This has led to a downward trend in average selling prices (ASPs) across market segments. Lower prices may entice purchasers to explore alternative solutions, prompting providers of alternative gynecological devices to further reduce their prices in a cross-category price competition. The formation of purchasing groups by clinics has bolstered buyers' leverage, compelling sellers to offer competitive prices to secure broader market access. The competitive landscape puts pressure on sellers to ensure their pricing aligns with buyer expectations and demands.

One significant trend in the U.S. market for gynecological devices is the avoidance, when possible, of hysterectomies as a treatment option. Fibroids and endometriosis affect a significant proportion of women in the United States, with 20-25% of reproductive-age women and 11% of women between 15 and 44 being affected, according to the U.S. National Institutes of Health (NIH). To address these conditions, physicians are increasingly turning to minimally invasive treatments such as hysteroscopic surgeries, uterine artery embolization, and endometrial ablation, when the condition permits. These alternative procedures offer less invasiveness, shorter recovery periods, and have become preferred options for patients seeking to avoid the need for hysterectomy.

U.S. GYNECOLOGICAL DEVICES MARKET SHARE INSIGHTS

Hologic, Medtronic, Cooper Surgical, and Minerva Surgical emerged as the dominant players in the U.S. gynecological device market, collectively capturing more than 50% of the total market share.

Hologic dominated the U.S. gynecological device market with its strong presence in various segments, including global endometrial ablation, hysteroscopic morcellators, endoscopes, and fluid management devices.

Medtronic secured the second position, competing in the morcellator and fluid management device markets. Their TruClear™ Hysteroscopic morcellator contributed significantly to their market share in the morcellator device segment.

Minerva Surgical held the fourth position, participating in the global endometrial ablation, gynecological endoscope, morcellator, and fluid management markets. Their acquisition of the intrauterine portfolio from Boston Scientific in 2020 further strengthened their position.

Cooper Surgical emerged as the leading competitor in the assisted reproduction technology device, gynecological endoscope, and HSG catheter segments, contributing to their third-leading market share in the U.S. gynecological device market.

SEGMENTS COVERED

  • Assisted reproduction technology devices
  • Global endometrial ablation
  • Uterine fibroid embolization devices
  • Gynecological endoscopes
  • Gynecological resection electrodes
  • Morcellator devices
  • Pelvic floor electrical stimulation devices
  • Fluid management devices
  • Pelvic organ prolapse repair devices
  • Hysterosalpingography (HSG) catheters

Table of Contents

1. Executive Summary
U.S. Gynecological Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
2. Impact of Covid-19 on the U.S. Gynecological Device Market
2.1 Introduction
2.2 Analysis by Market Segment
2.2.1 Best Case Scenario
2.2.2 Base Case Scenario
2.2.3 Worst Case Scenario
3. Disease Overview
3.1 Basic Anatomy
3.2 Disease Treatment and Diagnostic
3.2.1 Introduction
3.2.2 General Diagnostics
3.2.3 Assisted Reproduction Technologies (Art)
3.2.3.1 Art Costs
3.2.4 Abnormal Uterine Bleeding
3.2.5 Gynecologic Cancer and Tumors in Reproductive System
3.2.6 Female Sterilization
3.2.7 Urinary Incontinence
3.2.8 Pelvic Organ Prolapse
3.3 Patient Demographics
3.3.1 Assisted Reproduction Technologies (Art)
3.3.2 Abnormal Uterine Bleeding
3.3.3 Gynecologic Cancer and Tumors in Reproductive System
3.3.4 Pelvic Organ Prolapse
3.3.5 Endometriosis
3.3.6 Polycystic Ovary Syndrome
3.3.7 Female Sterilization
4. Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Assisted Reproduction Technology Device
4.2.2 Global Endometrial Ablation Market
4.2.3 Uterine Fibroid Embolization Device
4.2.4 Gynecological Endoscopes
4.2.5 Gynecological Resection Electrode
4.2.6 Gynecological Morcellators
4.2.7 Pelvic Floor Electrical Stimulation Device
4.2.8 Fluid Management Device
4.2.9 Pelvic Organ Prolapse Repair Device
4.2.10 Hsg Catheter
4.2.11 Uterine Manipulators
4.3 Regulatory Issues and Recalls
4.3.1 Assisted Reproduction Technology Device Market
4.3.2 Gynecological Endoscope Market
4.3.3 Gynecological Resection Electrode Market
4.3.4 Morcellator Market
4.3.5 Fluid Management Device Market
4.3.6 Pelvic Organ Prolapse Repair Device Market
4.3.7 Hsg Catheter Market
4.3.8 Uterine Manipulator Market
4.4 Clinical Trials
4.4.1 Assisted Reproduction Technology Device
4.4.2 Global Endometrial Ablation
4.4.3 Uterine Fibroid Embolization Device
4.4.4 Gynecological Endoscopes
4.4.5 Gynecological Morcellators
4.4.6 Pelvic Floor Electrical Stimulation Device
4.4.7 Pelvic Organ Prolapse Repair Device
4.4.8 Uterine Manipulators
5. U.S. Gynecological Device Market Overview
5.1 Introduction
5.2 Market Overview and Trend Analysis
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis
5.5 Mergers and Acquisitions
5.6 Company Profiles
5.6.1 Boston Scientific
5.6.2 Coloplast
5.6.3 Cooper Surgical
5.6.4 Hologic
5.6.5 Laborie Medical
5.6.6 Medtronic
5.6.7 Merit Medical Systems
5.6.8 Minerva Surgical
5.6.9 Olympus
5.6.10 Richard Wolf
5.7 SWOT Analysis
5.7.1 Boston Scientific
5.7.2 Coloplast
5.7.3 Cooper Surgical
5.7.4 Hologic
5.7.5 Laborie Medical
5.7.6 Medtronic
5.7.7 Merit Medical Systems
5.7.8 Minerva Surgical
5.7.9 Olympus
5.7.10 Richard Wolf
6. Procedure Numbers
6.1 Introduction
6.1.1 Ovarian Cancer Incidence
6.1.2 Pelvic Screens
6.2 Procedures Number Overview
6.2.1 Fallopian Tube Procedures
6.2.2 Assisted Reproduction Technology Procedures by Type
6.2.3 Cervical Repair and Biopsy Procedures
6.2.4 Global Endometrial Ablation Procedures
6.2.4.1 Thermal Ablation Procedures
6.2.4.2 Hydrothermal Ablation Procedures
6.2.4.3 Radiofrequency Ablation Procedures
6.2.4.4 Cryoablation Procedures
6.2.5 Uterine Fibroid Embolization Procedures by Type
6.2.6 Gynecological Endoscope Procedures
6.2.7 Morcellation Procedures
6.2.8 Vaginal Procedures
6.2.9 Pelvic Organ Prolapse Procedures by Type
6.2.10 Hsg Catheter Procedures by Type
6.2.11 Myomectomy Procedures
6.2.12 Hysterectomy Procedures
6.2.12.1 Hysterectomy Procedures by Type
6.2.12.1 Hysterectomy Procedures by Approach
7. Assisted Reproduction Technology Device Market
7.1 Introduction
7.1.1 Media
7.1.2 Vitrification
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Oocyte Retrieval Needle Market
7.3.2 Micropipette Market
7.3.2.1 Flexible Pipette Market
7.3.2.2 Icsi Pipette Market
7.3.3 Embryo Transfer Catheter Market
7.3.4 Reproduction Media Market
7.3.4.1 Culture Media Market
7.3.4.2 Sperm Preparation Media Market
7.3.4.3 Manipulation Media Market
7.3.4.4 Freeze/Thaw Media Market
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis
8. Global Endometrial Ablation Market
8.1 Introduction
8.1.1 Hydrothermal Ablation
8.1.2 Radiofrequency Ablation
8.1.3 Cryoablation
8.1.4 Roller-Ball Ablation
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Total Global Endometrial Ablation Market
8.3.2 Thermal Ablation Device Market
8.3.3 Hydrothermal Ablation Device Market
8.3.4 Radiofrequency Ablation Device Market
8.3.5 Cryoablation Device Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
9. Uterine Fibroid Embolization Device Market
9.1 Introduction
9.1.1 Microspheres
9.1.2 Polyvinyl Alcohol Particles
9.1.3 Drug-Eluting Particles
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Microsphere Market
9.3.2 Pva Particle Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis
10. Gynecological Endoscope Market
10.1 Introduction
10.1.1 Hysteroscopes
10.1.2 Colposcopes
10.1.3 Resectoscopes
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 Hysteroscope Market
10.3.1.1 Reusable Hysteroscope Market
10.3.1.2 Reusable Rigid Hysteroscope Market
10.3.1.3 Reusable Flexible Hysteroscope Market
10.3.1.3.1 Video Flexible Hysteroscope Market
10.3.1.3.2 Fiber Flexible Hysteroscope Market
10.3.1.4 Disposable Hysteroscope Market
10.3.2 Colposcope Market
10.3.2.1 Video Colposcope Market
10.3.2.2 Non-Video Colposcope Market
10.3.3 Resectoscope Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis
11. Gynecological Resection Electrode Market
11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 Monopolar Loop Electrode Market
11.3.2 Bipolar Loop Electrode Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis
12. Morcellator Market
12.1 Introduction
12.2 Market Analysis and Forecast
12.2.1 Laparoscopic Morcellator Market
12.2.2 Hysteroscopic Morcellator Market
12.3 Drivers and Limiters
12.3.1 Market Drivers
12.3.2 Market Limiters
12.4 Competitive Market Share Analysis
13. Pelvic Floor Electrical Stimulation Device Market
13.1 Introduction
13.2 Market Overview
13.3 Market Analysis and Forecast
13.3.1 Home-Based Pfes Device Market
13.3.2 Office-Based Pfes Device Market
13.4 Drivers and Limiters
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 Competitive Market Share Analysis
14. Fluid Management Device Market
14.1 Introduction
14.2 Market Overview
14.3 Market Analysis and Forecast
14.3.1 Fluid Management Equipment Market
14.3.2 Fluid Management Tubing Market
14.4 Drivers and Limiters
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 Competitive Market Share Analysis
15. Pelvic Organ Prolapse Repair Device Market
15.1 Introduction
15.2 Market Overview
15.3 Market Analysis and Forecast
15.3.1 Transvaginal Mesh Market
15.3.2 Sacrocolpopexy Mesh Market
15.4 Drivers and Limiters
15.4.1 Market Drivers
15.4.2 Market Limiters
15.5 Competitive Market Share Analysis
16. Hsg Catheter Market
16.1 Introduction
16.2 Market Analysis and Forecast
16.3 Drivers and Limiters
16.3.1 Market Drivers
16.3.2 Market Limiters
16.4 Competitive Market Share Analysis
17. Appendix: Uterine Manipulator Market
17.1 Introduction
17.2 Market Analysis and Forecast
17.3 Drivers and Limiters
17.3.1 Market Drivers
17.3.2 Market Limiters
17.4 Competitive Market Share Analysis
18. Abbreviations
List of Charts
Chart 1.1: Gynecological Device Market Value, U.S., 2019 - 20293
Chart 1.2: Gynecological Device Market Overview, U.S., 2022 & 20293
Chart 2.1: Multi-Scenario Gynecological Device Market Forecast, U.S., 2019 - 2029 (US$M)41
Chart 5.1: Gynecological Device Market by Segment, U.S., 2019 - 2029112
Chart 5.2: Leading Competitors, Gynecological Device Market, U.S., 2022125
Chart 6.1: Gynecological Procedures by Type, U.S., 2019 - 2029156
Chart 7.1: Assisted Reproduction Technology Device Market by Segment, U.S., 2019 - 2029180
Chart 7.2: Leading Competitors, Assisted Reproduction Technology Device Market, U.S., 2022198
Chart 8.1: Global Endometrial Ablation Market by Segment, U.S., 2019 - 2029203
Chart 8.2: Leading Competitors, Global Endometrial Ablation Market, U.S., 2022213
Chart 9.1: Uterine Fibroid Embolization Device Market by Segment, U.S., 2019 - 2029218
Chart 9.2: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2022225
Chart 10.1: Gynecological Endoscope Market by Segment, U.S., 2019 - 2029230
Chart 10.2: Leading Competitors, Hysteroscope Market, U.S., 2022253
Chart 11.1: Gynecological Electrosurgery Market, U.S., 2019 - 2029257
Chart 11.2: Leading Competitors, Gynecological Resection Device Market, U.S., 2022264
Chart 12.1: Gynecological Morcellator Market, U.S., 2019 - 2029268
Chart 12.2: Leading Competitors, Morcellator Market, U.S., 2022277
Chart 13.1: Pelvic Floor Electrical Stimulation Device Market by Segment, U.S., 2019 - 2029282
Chart 13.2: Leading Competitors, Pelvic Floor Electrical Stimulation Device Market, U.S., 2022291
Chart 14.1: Fluid Management Device Market by Segment, U.S., 2019 - 2029295
Chart 14.2: Leading Competitors, Fluid Management Device Market, U.S., 2022302
Chart 15.1: Pelvic Organ Prolapse Repair Device Market by Segment, U.S., 2019 - 2029307
Chart 15.2: Leading Competitors, Pelvic Organ Prolapse Repair Device Market, U.S., 2022314
Chart 16.1: HSG Catheter Market by segment, U.S., 2019 - 2029318
Chart 16.2: Leading Competitors, HSG Catheter Market, U.S., 2022323
Chart 17.1: Uterine Manipulator Market, U.S., 2019 - 2029326
Chart 17.2: Leading Competitors, Uterine Manipulator Market, U.S., 2022
List of Figures
Figure 1.1: Gynecological Device Market Share Ranking by Segment, U.S., 2022 (1 of 2)
Figure 1.2: Gynecological Device Market Share Ranking by Segment, U.S., 2022 (2 of 2)
Figure 1.3: Companies Researched in This Report (1 of 2)
Figure 1.4: Companies Researched in This Report (2 of 2)
Figure 1.5: Factors Impacting the Gynecological Device Market by Segment, U.S. (1 of 2)
Figure 1.6: Factors Impacting the Gynecological Device Market by Segment, U.S. (2 of 2)
Figure 1.7: Recent Events in the Gynecological Device Market, U.S., 2019 - 2023 (1 of 2)
Figure 1.8: Recent Events in the Gynecological Device Market, U.S., 2019 - 2023 (2 of 2)
Figure 1.9: Gynecological Device Procedures Covered (1 of 2)
Figure 1.10: Gynecological Device Procedures Covered (2 of 2)
Figure 1.11: Procedure Codes Investigated
Figure 1.12: Gynecological Device Markets Covered (1 of 2)
Figure 1.13: Gynecological Device Markets Covered (2 of 2)
Figure 1.14: Key Report Updates
Figure 1.15: Version History
Figure 2.1: Gynecological Market by Segment, Best Case Scenario, U.S., 2019 - 2029 (US$M) (1 of 2)
Figure 2.2: Gynecological Market by Segment, Best Case Scenario, U.S., 2019 - 2029 (US$M) (2 of 2)
Figure 2.3: Gynecological Market by Segment, Base Case Scenario, U.S., 2019 - 2029 (US$M) (1 of 2)
Figure 2.4: Gynecological Market by Segment, Base Case Scenario, U.S., 2019 - 2029 (US$M) (2 of 2)
Figure 2.5: Gynecological Market by Segment, Worst Case Scenario, U.S., 2019 - 2029 (US$M) (1 of 2)
Figure 2.6: Gynecological Market by Segment, Worst Case Scenario, U.S., 2019 - 2029 (US$M) (2 of 2)
Figure 3.1: Gynecological Disease Overview
Figure 3.2: ART Procedure Availability Overview
Figure 3.3: Female Sterilization Estimation
Figure 4.1: Assisted Reproduction Technology Device by Company (1 of 2)
Figure 4.2: Assisted Reproduction Technology Device by Company (2 of 2)
Figure 4.3: Global Endometrial Ablation Market by Company
Figure 4.4: Uterine Fibroid Embolization Device Market by Company
Figure 4.5: Gynecological Endoscope Market by Company (1 of 2)
Figure 4.6: Gynecological Endoscope Market by Company (2 of 2)
Figure 4.7: Gynecological Resection Electrode Market by Company
Figure 4.8: Morcellator Market by Company
Figure 4.9: Pelvic Floor Electrical Stimulation Device Market by Company
Figure 4.10: Fluid Management Device Market by Company
Figure 4.11: Pelvic Organ Prolapse Repair Device Market by Company
Figure 4.12: HSG Catheter Market by Company
Figure 4.13: Uterine Manipulator Market by Company
Figure 4.14: Class 2 Device Recall BIOPSY MEDIUM
Figure 4.15: Class 2 Device Recall LifeGlobal Fast Freeze Thawing Kit
Figure 4.16: Class 2 Device Recall Vitrification Freeze Kit
Figure 4.17: Class 2 Device Recall MediCult Vitrification Cooling Media
Figure 4.18: Class 3 Device Recall
Figure 4.19: Class 2 Device Recall Guardia Access Nano Embryo Transfer Catheter
Figure 4.20: Class 2 Device Recall Embryo Transfer Catheters/Sets
Figure 4.21: Class 2 Device Recall Advanced Endosee Cannula
Figure 4.22: Class 2 Device Recall HF Resection Electrodes
Figure 4.23: Class 2 Device Recall Covidien TruClear Hysteroscopic Tissue Removal System
Figure 4.24: Class 2 Device Recall PneumoLiner
Figure 4.25: Class 2 Device Recall HysteroLux Fluid Management System
Figure 4.26: Class 2 Device Recall Aquilex Fluid Control System Component: Bag Deflector
Figure 4.27: Class 2 Device Recall Colpassist Vaginal Positioning Device
Figure 4.28: Class 2 Device Recall Upsylon YMesh Kit with Colpassist Vaginal Positioning Device
Figure 4.29: Class 2 Device Recall VERITAS Collagen Matrix
Figure 4.30: Class 2 Device Recall Uphold Vaginal Support System
Figure 4.31: Class 2 Device Recall Posterior LITE w/ Capio SLIM
Figure 4.32: Class 2 Device Recall PFR Kit Pinnacle
Figure 4.33: Class 2 Device Recall McKesson
Figure 4.34: Class 2 Device Recall Cannula, Manipulator/Injector, Uterine
Figure 4.35: Class 2 Device Recall Advincula Delineator
Figure 4.36: The Impact of Past Coronavirus Disease 19 (COVID-19) Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles
Figure 4.37: Impact of pH Values of the Embryo Culture Medium on Success of In Vitro Fertilization (IVF) (ACIDOFIV)
Figure 4.38: Assessment of Embryo Viability and Re-expansion After Thawing in Blastocyst Stage Embryos
Figure 4.39: Heated and Non Heated Ovarian Aspiration Needle Protocol
Figure 4.40: Fresh Vs Frozen Surgical Sperm in IVF
Figure 4.41: Comparing Two Types of Needle for Oocytes Retrieval (NEEDLE)
Figure 4.42: Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer
Figure 4.43: Male Fertility and Sperm Cryopreservation
Figure 4.44: Embryo Transfer with Self-spent Culture Medium
Figure 4.45: EmbryoGlue as an Embryo Transfer Medium
Figure 4.46: Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates
Figure 4.47: NovaSure Study: Endometrial Ablation in Women with Heavy Menstrual Bleeding (RAMBOS)
Figure 4.48: Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ System
Figure 4.49: Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids
Figure 4.50: UA Versus UAE in Treatment of Fibroids
Figure 4.51: Satisfaction of Patients with Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial (SPARQLE)
Figure 4.52: A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery
Figure 4.53: Safety and Efficacy of Using PK Morcellator with Pneumoliner Containment Hysterectomy
Figure 4.54: Treatment of Missed Miscarriage with TRUCLEAR Tissue Removal System, a Feasibility Study
Figure 4.55: The Hysteroscopic Morcellator (HM)
Figure 4.56: Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy (RESMO)
Figure 4.57: A Randomized Controlled Trial of Electrical Stimulation to Treat Pelvic Floor Disorder
Figure 4.58: A Study of Fractional Carbon Dioxide Laser Treatment for Female Stress Urinary Incontinence
Figure 4.59: Evaluation of the Safety and Efficacy of Carbon Dioxide (CO2) Acupulse Laser Treatment on Urinary Stress Incontinence
Figure 4.60: the Effect of a New Type of Pelvic Floor Rehabilitation Device PHENIX U4+ on the Treatment of Urinary Incontinence
Figure 4.61: Electrical Stimulation in Women with Pelvic Organ Prolapse
Figure 4.62: Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Stress Urinary Incontinence Symptoms
Figure 4.63: Effect of External Electrical Stimulation and Pelvic Floor Muscle Training
Figure 4.64: Comparison of the Efficacy of Sacrocolpopexy, the Amreich-Richter Procedure and Transvaginal Mesh (SAME)
Figure 4.65: Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair (CASPO)
Figure 4.66: SCP vs HUSLS for Pelvic Organ Prolapse Repair
Figure 4.67: Evaluation of Safety and Efficacy of the Apyx™ Device for the Repair of Pelvic Organ Prolapse (POP)
Figure 4.68: Restorelle® Mesh Versus Native Tissue Repair for Prolapse
Figure 4.69: Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse
Figure 4.70: Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial (ACRAS)
Figure 4.71: Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial (MANEC)
Figure 4.72: Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study (proMUCEI)
Figure 4.73: Pilot Trial of the Robotic Uterine Manipulator
Figure 4.74: Trial of YUMI Uterine Manipulator
Figure 5.1: Gynecological Market by Segment, U.S., 2019 - 2029 (US$M) (1 of 2)
Figure 5.2: Gynecological Market by Segment, U.S., 2019 - 2029 (US$M) (2 of 2)
Figure 5.3: Leading Competitors, Gynecological Device Market, U.S., 2022 (1 of 2)
Figure 5.4: Leading Competitors, Gynecological Device Market, U.S., 2022 (2 of 2)
Figure 5.5: SWOT Analysis, Boston Scientific
Figure 5.6: SWOT Analysis, Coloplast
Figure 5.7: SWOT Analysis, Cooper Surgical
Figure 5.8: SWOT Analysis, Hologic
Figure 5.9: SWOT Analysis, Laborie Medical
Figure 5.10: SWOT Analysis, Medtronic
Figure 5.11: SWOT Analysis, Merit Medical Systems
Figure 5.12: SWOT Analysis, Minerva Surgical
Figure 5.13: SWOT Analysis, Olympus
Figure 5.14: SWOT Analysis, Richard Wolf
Figure 6.1: Ovarian Cancer Incidence, U.S., 2019 - 2029
Figure 6.2: Pelvic Screens, U.S., 2019 - 2029
Figure 6.3: Procedure Codes Investigated
Figure 6.4: Gynecological Procedures by Type, U.S., 2019 - 2029 (1 of 2)
Figure 6.5: Gynecological Procedures by Type, U.S., 2019 - 2029 (2 of 2)
Figure 6.6: Fallopian Tube Procedures, U.S., 2019 - 2029
Figure 6.7: Assisted Reproduction Technology Procedures by Type, U.S., 2019 - 2029
Figure 6.8: Cervical Repair and Biopsy Procedures, U.S., 2019 - 2029
Figure 6.9: Global Endometrial Ablation Procedures by Modality, U.S., 2019 - 2029
Figure 6.10: Uterine Fibroid Embolization Procedures by Type, U.S., 2019 - 2029
Figure 6.11: Gynecological Endoscopy Procedures, U.S., 2019 - 2029
Figure 6.12: Morcellation Procedures by Type, U.S., 2019 - 2029
Figure 6.13: Vaginal Procedures, U.S., 2019 - 2029
Figure 6.14: Pelvic Organ Prolapse Procedures by Type, U.S., 2019 - 2029
Figure 6.15: HSG Catheter Procedures by Type, U.S., 2019 - 2029
Figure 6.16: Myomectomy Procedures, U.S., 2019 - 2029
Figure 6.17: Hysterectomy Procedures by Type, U.S., 2019 - 2029
Figure 6.18: Hysterectomy Procedures by Approach, U.S., 2019 - 2029
Figure 7.1: Assisted Reproduction Technology Device Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 7.2: Oocyte Retrieval Needle Market, U.S., 2019 - 2029
Figure 7.3: Micropipette Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 7.4: Micropipette Market, U.S., 2019 - 2029
Figure 7.5: Flexible Pipette Market, U.S., 2019 - 2029
Figure 7.6: ICSI Pipette Market, U.S., 2019 - 2029
Figure 7.7: Embryo Transfer Catheter Market, U.S., 2019 - 2029
Figure 7.8: Reproduction Media Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 7.9: Reproduction Media Market, U.S., 2019 - 2029
Figure 7.10: Culture Media Market, U.S., 2019 - 2029
Figure 7.11: Sperm Preparation Media Market, U.S., 2019 - 2029
Figure 7.12: Manipulation Media Market, U.S., 2019 - 2029
Figure 7.13: Freeze/Thaw Media Market, U.S., 2019 - 2029
Figure 7.14: Leading Competitors, Assisted Reproduction Technology Device Market, U.S., 2022
Figure 8.1: Global Endometrial Ablation Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 8.2: Total Global Endometrial Ablation Market, U.S., 2019 - 2029
Figure 8.3: Thermal Ablation Device Market, U.S., 2019 - 2029
Figure 8.4: Hydrothermal Ablation Device Market, U.S., 2019 - 2029
Figure 8.5: Radiofrequency Ablation Device Market, U.S., 2019 - 2029
Figure 8.6: Cryoablation Device Market, U.S., 2019 - 2029
Figure 8.7: Leading Competitors, Global Endometrial Ablation Market, U.S., 2022
Figure 9.1: Uterine Fibroid Embolization Device Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 9.2: Microsphere Market, U.S., 2019 - 2029
Figure 9.3: PVA Particle Market, U.S., 2019 - 2029
Figure 9.4: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2022
Figure 10.1: Gynecological Endoscope Market, U.S., 2019 - 2029 (US$M)
Figure 10.2: Total Hysteroscope Market, U.S., 2019 - 2029
Figure 10.3: Total Reusable Hysteroscope Market, U.S., 2019 - 2029
Figure 10.4: Reusable Rigid Hysteroscope Market, U.S., 2019 - 2029
Figure 10.5: Reusable Flexible Hysteroscope Market by Segment, U.S., 2019 - 2029
Figure 10.6: Total Reusable Flexible Hysteroscope Market, U.S., 2019 - 2029
Figure 10.7: Video Flexible Hysteroscope Market, U.S., 2019 - 2029
Figure 10.8: Fiber Flexible Hysteroscope Market, U.S., 2019 - 2029
Figure 10.9: Disposable Hysteroscope Market, U.S., 2019 - 2029
Figure 10.10: Total Colposcope Market, U.S., 2019 - 2029
Figure 10.11: Colposcope Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 10.12: Video Colposcope Market, U.S., 2019 - 2029
Figure 10.13: Non-Video Colposcope Market, U.S., 2019 - 2029
Figure 10.14: Resectoscope Market, U.S., 2019 - 2029
Figure 10.15: Leading Competitors, Gynecological Endoscope Market, U.S., 2022
Figure 11.1: Gynecological Electrosurgery Device Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 11.2: Monopolar Loop Electrode Market, U.S., 2019 - 2029
Figure 11.3: Bipolar Loop Electrode Market, U.S., 2019 - 2029
Figure 11.4: Leading Competitors, Gynecological Resection Device Market, U.S., 2022
Figure 12.1: Morcellator Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 12.2: Laparoscopic Morcellator Market, U.S., 2019 - 2029
Figure 12.3: Hysteroscopic Morcellator Market, U.S., 2019 - 2029
Figure 12.4: Leading Competitors, Morcellator Market, U.S., 2022
Figure 13.1: Pelvic Floor Electrical Stimulation Device Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 13.2: Home-Based PFES Device Market, U.S., 2019 - 2029
Figure 13.3: Office-Based PFES Device Market, U.S., 2019 - 2029
Figure 13.4: Leading Competitors, Pelvic Floor Electrical Stimulation Device Market, U.S., 2022
Figure 14.1: Fluid Management Device Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 14.2: Fluid Management Equipment Market, U.S., 2019 - 2029
Figure 14.3: Fluid Management Tubing Market, U.S., 2019 - 2029
Figure 14.4: Leading Competitors, Fluid Management Device Market, U.S., 2022
Figure 15.1: Pelvic Organ Prolapse Repair Device Market by Segment, U.S., 2019 - 2029 (US$M)
Figure 15.2: Sacrocolpopexy Mesh Market, U.S., 2019 - 2029
Figure 15.3: Leading Competitors, Pelvic Organ Prolapse Repair Device Market, U.S., 2022
Figure 16.1: HSG Catheter Market, U.S., 2019 - 2029
Figure 16.2: Leading Competitors, HSG Catheter Market, U.S., 2022
Figure 17.1: Uterine Manipulator Market, U.S., 2019 - 2029
Figure 17.2: Leading Competitors, Uterine Manipulator Market, U.S., 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AcuVu
  • Adler Instrument
  • Applied Medical
  • Artisan Medical
  • ARTS Media
  • Athena Feminine Technology
  • Atlantic Therapeutics
  • BD
  • Biop Medical
  • Bioteque America
  • Blue Endo
  • Caldera Medical
  • CeloNova BioSciences
  • Channel Medsystems
  • Coloplast
  • ConMed
  • Cook Medical
  • Cooper Surgical
  • Corinth MedTech
  • CryoLogic
  • Donne Vie Medical Technology
  • Edan Instruments
  • Espiner Medical
  • Ethicon
  • FemDx Medsystems
  • Fujifilm
  • Genea Biomedx
  • Gynecare Innovation System
  • Gynex Corporation
  • Gyrus Medical
  • Hadleigh Health Technologies
  • Hamilton Thorne Incorporated
  • Hayden Medical
  • Hologic
  • Hysterovue
  • Illumigyn
  • InControl Medical
  • InVitroCare
  • IVFStore
  • K-fit
  • Karl Storz
  • Kitazato USA
  • Kronner Medical
  • Laborie
  • Lina Medical
  • Lutech Industries
  • McKesson Medical-Surgical
  • MedGyn
  • Meditrina
  • Medtronic
  • Merit Medical
  • Mermaid Medical
  • Minerva Surgical
  • MobileODT
  • Monarch Medical Products
  • MPM Medical Supply
  • Nipro
  • Olympus
  • Peters Surgical
  • Redi-tech Medical Products
  • Renovia
  • Richard Wolf
  • Rocket Medical
  • Schoelly Fiberoptic
  • Seiler Medical
  • Shenzhen Vita Vitro Biotech
  • Sonocath
  • STI Medical Systems
  • Strauss Surgical
  • Stryker
  • Sunlight Medical
  • TensCare
  • The Prometheus Group
  • Thomas Medical
  • TriSalus Life Sciences
  • UNICOUtah Medical
  • Varian
  • Vitrolife
  • Vitromed
  • Win Health
  • Z&Z Medical
  • Zhejiang Horizon Medical Technology
  • Zynex